Sabby Management’s Reviva Pharmaceuticals RVPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $64.8K | Buy |
+169,921
| New | +$64.8K | 0.12% | 26 |
|
|
2025
Q1 | – | Hold |
0
| – | – | – | 44 |
|
|
2024
Q4 | – | Hold |
0
| – | – | – | 31 |
|
|
2024
Q3 | – | Sell |
-236,997
| Closed | -$303K | – | 47 |
|
|
2024
Q2 | $303K | Buy |
+236,997
| New | +$303K | 0.2% | 7 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 67 |
|
|
2023
Q4 | – | Sell |
-44,593
| Closed | -$218K | – | 74 |
|
|
2023
Q3 | $218K | Buy |
+44,593
| New | +$218K | 0.16% | 28 |
|
|
2023
Q2 | – | Sell |
-28,610
| Closed | -$120K | – | 93 |
|
|
2023
Q1 | $120K | Sell |
28,610
-5,890
| -17% | -$24.7K | 0.1% | 47 |
|
|
2022
Q4 | $147K | Buy |
34,500
+4,500
| +15% | +$19.1K | 0.13% | 48 |
|
|
2022
Q3 | $48K | Buy |
+30,000
| New | +$48K | 0.06% | 65 |
|
|
2021
Q2 | – | Sell |
-418,437
| Closed | -$2.4M | – | 110 |
|
|
2021
Q1 | $2.4M | Buy |
418,437
+60,137
| +17% | +$345K | 0.47% | 20 |
|
|
2020
Q4 | $3.13M | Buy |
+358,300
| New | +$3.13M | 0.6% | 6 |
|